Evidence map›Paper›PMID 32630597›Full record

ArticleInternational journal of molecular sciences2020

Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.

Sujin Kim, Hyunju Chung, Han Ngoc Mai, Yunkwon Nam, Soo Jung Shin, Yong Ho Park, Mi Joo Chung, Jong Kil Lee, Hak Young Rhee, Geon-Ho Jahng and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Radiotherapy for non-cancer diseases: benefits and long-term risks.International journal of radiation biology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. A glance through the effects of CD4Computational and structural biotechnology journal · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Sujin KimDepartment of Biochemistry, College of Medicine, Konyang University, 158, Gwanjeodong-ro, Seo-gu, Daejeon 35365, Korea.
Hyunju ChungDepartment of Core Research Laboratory, Medical Science Research Institute, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea.ORCID 0000-0002-2312-3199
Han Ngoc MaiDepartment of Radiation Oncology, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea.
Yunkwon NamDepartment of Biochemistry, College of Medicine, Konyang University, 158, Gwanjeodong-ro, Seo-gu, Daejeon 35365, Korea.
Soo Jung ShinDepartment of Biochemistry, College of Medicine, Konyang University, 158, Gwanjeodong-ro, Seo-gu, Daejeon 35365, Korea.
Yong Ho ParkDepartment of Biochemistry, College of Medicine, Konyang University, 158, Gwanjeodong-ro, Seo-gu, Daejeon 35365, Korea.
Mi Joo ChungDepartment of Radiation Oncology, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea.
Jong Kil LeeDepartment of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, 02447, Korea.
Hak Young RheeDepartment of Neurology, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea.ORCID 0000-0002-3016-2591
Geon-Ho JahngDepartment of Radiology, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea.
Youngkyong KimDepartment of Radiation Oncology, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, 02447, Korea.
Yu Jin LimDepartment of Radiation Oncology, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, 02447, Korea.
Moonkyoo KongDepartment of Radiation Oncology, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, 02447, Korea.
Minho MoonDepartment of Biochemistry, College of Medicine, Konyang University, 158, Gwanjeodong-ro, Seo-gu, Daejeon 35365, Korea.
Weon Kuu ChungDepartment of Radiation Oncology, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea.
Kyung Hee University Hospital at Gangdong · KRKonyang University · KRKyung Hee University Medical Center · KRKyung Hee University · KR

Funding

Cooperative Research Program for Agriculture Science and Technology Development PJ01319901 to M.M.Cooperative Research Program for Agriculture Science and Technology Development PJ01428603 to M.M.Ministry of SME and Startups Project Number S2668252National Research Foundation of Korea NRF-2016R1D1A1B03935770 to W.K.C.National Research Foundation of Korea NRF-2018R1D1A3B07041059 to M.M.
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common type of dementia. AD involves major pathologies such as amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain. During the progression of AD, microglia can be polarized from anti-inflammatory M2 to pro-inflammatory M1 phenotype. The activation of triggering receptor expressed on myeloid cells 2 (TREM2) may result in microglia phenotype switching from M1 to M2, which finally attenuated Aβ deposition and memory loss in AD. Low-dose ionizing radiation (LDIR) is known to ameliorate Aβ pathology and cognitive deficits in AD; however, the therapeutic mechanisms of LDIR against AD-related pathology have been little studied. First, we reconfirm that LDIR (two Gy per fraction for five times)-treated six-month 5XFAD mice exhibited (1) the reduction of Aβ deposition, as reflected by thioflavins S staining, and (2) the improvement of cognitive deficits, as revealed by Morris water maze test, compared to sham-exposed 5XFAD mice. To elucidate the mechanisms of LDIR-induced inhibition of Aβ accumulation and memory loss in AD, we examined whether LDIR regulates the microglial phenotype through the examination of levels of M1 and M2 cytokines in 5XFAD mice. In addition, we investigated the direct effects of LDIR on lipopolysaccharide (LPS)-induced production and secretion of M1/M2 cytokines in the BV-2 microglial cells. In the LPS- and LDIR-treated BV-2 cells, the M2 phenotypic marker CD206 was significantly increased, compared with LPS- and sham-treated BV-2 cells. Finally, the effect of LDIR on M2 polarization was confirmed by detection of increased expression of TREM2 in LPS-induced BV2 cells. These results suggest that LDIR directly induced phenotype switching from M1 to M2 in the brain with AD. Taken together, our results indicated that LDIR modulates LPS- and Aβ-induced neuroinflammation by promoting M2 polarization via TREM2 expression, and has beneficial effects in the AD-related pathology such as Aβ deposition and memory loss.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsAnti-Inflammatory AgentsBiomarkersBrainCognition DisordersCognitive DysfunctionCytokinesDisease Models, AnimalLipopolysaccharidesMaleMembrane GlycoproteinsMiceMice, Inbred C57BLMice, TransgenicAmyloid beta-PeptidesAnti-Inflammatory AgentsBiomarkersCytokinesLipopolysaccharidesMembrane GlycoproteinsReceptors, ImmunologicTREM2 protein, humanAlzheimer’s diseaseamyloid-betalow-dose ionizing radiationmicrogliaTREM2, M1/M2

Identifiers

PMID32630597
PMCPMC7353052
OpenAlexW3037895802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.